Davide Campari-Milano (OTCMKTS:DVDCF – Get Rating) has been given an average recommendation of “Hold” by the twelve brokerages that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $12.31.
A number of research firms have commented on DVDCF. Credit Suisse Group raised Davide Campari-Milano from an “underperform” rating to a “neutral” rating and set a $11.70 price target for the company in a research report on Wednesday, April 6th. Deutsche Bank Aktiengesellschaft upped their price target on Davide Campari-Milano to €12.55 ($13.49) in a research report on Friday, April 1st. Citigroup raised Davide Campari-Milano from a “neutral” rating to a “buy” rating and set a $12.30 target price for the company in a research report on Friday, April 1st. Barclays decreased their target price on Davide Campari-Milano to €11.60 ($12.47) in a research report on Thursday, April 14th. Finally, Berenberg Bank decreased their target price on Davide Campari-Milano from €14.00 ($15.05) to €12.50 ($13.44) in a research report on Tuesday, March 1st.
Shares of DVDCF stock opened at $11.74 on Wednesday. The business has a 50-day moving average of $11.22 and a 200 day moving average of $13.10. Davide Campari-Milano has a 1-year low of $9.70 and a 1-year high of $15.23.
Davide Campari-Milano N.V., together with its subsidiaries, markets and distributes alcoholic and non-alcoholic beverages in the Americas, the Middle East, Africa, Europe, and the Asia-Pacific. It offers range of spirits categories, including aperitif, vodka, liqueurs, bitters, whisky, tequila, rum, gin, and cognac, as well as champagne and non-alcoholic aperitif under approximately 50 brands, such as Aperol, Campari, SKYY, Wild Turkey, Grand Marnier, Appleton Estate, Wray & Nephew Overproof, and other brands.
- Get a free copy of the StockNews.com research report on Davide Campari-Milano (DVDCF)
- Is Turning Point Therapeutics Stock at a Turning Point?
- Buy Haliburton On Post-Earnings Weakness
- Constellation Brands Stock is Launching Towards New Highs
- 3 Analyst Favorite Blue-Chip Stocks to Buy Now
- Does PNC Financial Stock Belong in Your Portfolio?
Receive News & Ratings for Davide Campari-Milano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davide Campari-Milano and related companies with MarketBeat.com's FREE daily email newsletter.